In Alzheimer’s disease, CX3CL1 expression is reduced in the main areas where the pathological changes occur and its expression levels reflect the progression of the disease (Duan et al., 2008). Here, CX3CL1 is linked to early-onset autosomal dominant Alzheimer disease.